GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Market Cap

Nuvation Bio (Nuvation Bio) Market Cap : $1,189.12 Mil (As of Apr. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nuvation Bio's share price for the quarter that ended in Sep. 2021 was $9.94. Nuvation Bio's Shares Outstanding (EOP) for the quarter that ended in Sep. 2021 was 217.78 Mil. Therefore, Nuvation Bio's market cap for the quarter that ended in Sep. 2021 was $2,164.69 Mil.

Nuvation Bio's quarterly market cap declined from Mar. 2021 ($2,274.44 Mil) to Jun. 2021 ($2,027.34 Mil) but then increased from Jun. 2021 ($2,027.34 Mil) to Sep. 2021 ($2,164.69 Mil).

Nuvation Bio's annual market cap stayed the same from . 20 ($0.00 Mil) to . 20 ($0.00 Mil) but then increased from . 20 ($0.00 Mil) to Dec. 2020 ($215.94 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nuvation Bio's Enterprise Value for Today is $1,107.14 Mil.


Nuvation Bio Market Cap Historical Data

The historical data trend for Nuvation Bio's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Market Cap Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Market Cap
215.94 -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Market Cap Get a 7-Day Free Trial 215.94 2,274.44 2,027.34 2,164.69 -

Competitive Comparison of Nuvation Bio's Market Cap

For the Biotechnology subindustry, Nuvation Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Market Cap distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Market Cap falls into.



Nuvation Bio Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nuvation Bio's Market Cap for the fiscal year that ended in Dec. 2020 is calculated as

Market Cap (A: Dec. 2020 )=Share Price (A: Dec. 2020 )*Shares Outstanding (EOP) (A: Dec. 2020 )
=$11.7*18.4562
=$

Nuvation Bio's Market Cap for the quarter that ended in Sep. 2021 is calculated as

Market Cap (Q: Sep. 2021 )=Share Price (Q: Sep. 2021 )*Shares Outstanding (EOP) (Q: Sep. 2021 )
=$9.94*217.776
=$2,164.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Nuvation Bio Market Cap Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.